1. Home
  2. LINC vs IVA Comparison

LINC vs IVA Comparison

Compare LINC & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lincoln Educational Services Corporation

LINC

Lincoln Educational Services Corporation

HOLD

Current Price

$22.29

Market Cap

813.3M

Sector

Real Estate

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$3.42

Market Cap

796.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LINC
IVA
Founded
1946
2011
Country
United States
France
Employees
N/A
77
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
813.3M
796.1M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
LINC
IVA
Price
$22.29
$3.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
10
Target Price
★ $45.00
$16.20
AVG Volume (30 Days)
694.3K
★ 1.4M
Earning Date
05-11-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 100.00
N/A
EPS
★ 0.20
N/A
Revenue
★ $261,853,000.00
N/A
Revenue This Year
$15.16
N/A
Revenue Next Year
$9.02
$751.20
P/E Ratio
$119.40
★ N/A
Revenue Growth
★ 32.98
N/A
52 Week Low
$17.29
$3.11
52 Week High
$56.34
$7.98

Technical Indicators

Market Signals
Indicator
LINC
IVA
Relative Strength Index (RSI) 23.57 26.41
Support Level N/A $3.35
Resistance Level $25.77 $4.78
Average True Range (ATR) 1.15 0.24
MACD 0.32 -0.09
Stochastic Oscillator 9.91 15.93

Price Performance

Historical Comparison
LINC
IVA

About LINC Lincoln Educational Services Corporation

Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include: Campus Operations and Transitional. The majority of the revenue is generated from the Campus Operations segment, which includes all campuses that are continuing in operation and contribute to the company's core operations and performance.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.

Share on Social Networks: